ALS Organizations Collaborate to Advance New Therapeutic into Human Trials - AT-1501 | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
From www.alsa.org - November 29, 2018 3:32 AM

Boston, MA (November 28, 2018) — Several ALS organizations announced on Wednesday that the first participant was successfully given a dose of AT-1501 in the first in-human trial of the potential treatment for ALS. AT-1501 was developed by the ALS Therapy Development Institute (ALS TDI), with support from The ALS Association, ALS ONE, and ALS Finding a Cure®, and is being brought into trials by Anelixis Therapeutics, Inc., a for-profit subsidiary of ALS TDI.